|
Volumn 159, Issue 9, 2002, Pages 1593-1595
|
Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
RISPERIDONE;
SEROTONIN 2A RECEPTOR;
ADULT;
ARTICLE;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG RECEPTOR BINDING;
FEMALE;
GENETIC POLYMORPHISM;
GENOTYPE;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NEGATIVE SYNDROME;
PRIORITY JOURNAL;
PROGNOSIS;
RECEPTOR GENE;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
ADULT;
ANTIPSYCHOTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GENOTYPE;
HUMANS;
MALE;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
PROGNOSIS;
PSYCHIATRIC STATUS RATING SCALES;
RECEPTOR, SEROTONIN, 5-HT2A;
RECEPTORS, SEROTONIN;
RISPERIDONE;
SCHIZOPHRENIA;
SCHIZOPHRENIC PSYCHOLOGY;
TREATMENT OUTCOME;
|
EID: 0036713871
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.159.9.1593 Document Type: Article |
Times cited : (137)
|
References (11)
|